164 related articles for article (PubMed ID: 36006892)
21. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.
Lim DA; Tarapore P; Chang E; Burt M; Chakalian L; Barbaro N; Chang S; Lamborn KR; McDermott MW
J Neurooncol; 2009 Jul; 93(3):349-54. PubMed ID: 19169651
[TBL] [Abstract][Full Text] [Related]
22. Temporal relationship between levetiracetam nonadherence and breakthrough seizures in a preclinical model of temporal lobe epilepsy.
Guignet M; Vuong J; Martinez A; Ballapapinan T; White HS
Epilepsia; 2024 Feb; 65(2):497-510. PubMed ID: 38031477
[TBL] [Abstract][Full Text] [Related]
23. A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis.
Inaba K; Menaker J; Branco BC; Gooch J; Okoye OT; Herrold J; Scalea TM; Dubose J; Demetriades D
J Trauma Acute Care Surg; 2013 Mar; 74(3):766-71; discussion 771-3. PubMed ID: 23425733
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of levetiracetam as adjunctive treatment for refractory canine epilepsy: a randomized, placebo-controlled, crossover trial.
Muñana KR; Thomas WB; Inzana KD; Nettifee-Osborne JA; McLucas KJ; Olby NJ; Mariani CJ; Early PJ
J Vet Intern Med; 2012; 26(2):341-8. PubMed ID: 22295869
[TBL] [Abstract][Full Text] [Related]
25. Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study.
Rossetti AO; Jeckelmann S; Novy J; Roth P; Weller M; Stupp R
Neuro Oncol; 2014 Apr; 16(4):584-8. PubMed ID: 24311644
[TBL] [Abstract][Full Text] [Related]
26. The treatment of neonatal seizures: focus on Levetiracetam.
Loiacono G; Masci M; Zaccara G; Verrotti A
J Matern Fetal Neonatal Med; 2016; 29(1):69-74. PubMed ID: 25385270
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
Milligan TA; Hurwitz S; Bromfield EB
Neurology; 2008 Aug; 71(9):665-9. PubMed ID: 18725591
[TBL] [Abstract][Full Text] [Related]
28. Phenytoin versus Leviteracetam for seizure prophylaxis after brain injury - a meta analysis.
Zafar SN; Khan AA; Ghauri AA; Shamim MS
BMC Neurol; 2012 May; 12():30. PubMed ID: 22642837
[TBL] [Abstract][Full Text] [Related]
29. Levetiracetam use in critically ill patients.
Szaflarski JP; Meckler JM; Szaflarski M; Shutter LA; Privitera MD; Yates SL
Neurocrit Care; 2007; 7(2):140-7. PubMed ID: 17607530
[TBL] [Abstract][Full Text] [Related]
30. Rapid onset of action of levetiracetam in refractory epilepsy patients.
French J; Arrigo C
Epilepsia; 2005 Feb; 46(2):324-6. PubMed ID: 15679515
[TBL] [Abstract][Full Text] [Related]
31. Early and Late Posttraumatic Epilepsy in the Setting of Traumatic Brain Injury: A Meta-analysis and Review of Antiepileptic Management.
Wilson CD; Burks JD; Rodgers RB; Evans RM; Bakare AA; Safavi-Abbasi S
World Neurosurg; 2018 Feb; 110():e901-e906. PubMed ID: 29196247
[TBL] [Abstract][Full Text] [Related]
32. Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: A prospective, randomized study.
Gujjar AR; Nandhagopal R; Jacob PC; Al-Hashim A; Al-Amrani K; Ganguly SS; Al-Asmi A
Seizure; 2017 Jul; 49():8-12. PubMed ID: 28528211
[TBL] [Abstract][Full Text] [Related]
33. An interaction study of Ocimum sanctum L. and levetiracetam in pentylenetetrazole kindling model of epilepsy.
Sarangi SC; Pattnaik SS; Katyal J; Kaleekal T; Dinda AK
J Ethnopharmacol; 2020 Mar; 249():112389. PubMed ID: 31739106
[TBL] [Abstract][Full Text] [Related]
34. Levetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data.
De Smedt T; Raedt R; Vonck K; Boon P
CNS Drug Rev; 2007; 13(1):43-56. PubMed ID: 17461889
[TBL] [Abstract][Full Text] [Related]
35. Serum concentrations of Levetiracetam in epileptic patients: the influence of dose and co-medication.
May TW; Rambeck B; Jürgens U
Ther Drug Monit; 2003 Dec; 25(6):690-9. PubMed ID: 14639055
[TBL] [Abstract][Full Text] [Related]
36. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological treatments for preventing epilepsy following traumatic head injury.
Thompson K; Pohlmann-Eden B; Campbell LA; Abel H
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD009900. PubMed ID: 26259048
[TBL] [Abstract][Full Text] [Related]
38. Long-term comparison of GOS-E scores in patients treated with phenytoin or levetiracetam for posttraumatic seizure prophylaxis after traumatic brain injury.
Gabriel WM; Rowe AS
Ann Pharmacother; 2014 Nov; 48(11):1440-4. PubMed ID: 25169249
[TBL] [Abstract][Full Text] [Related]
39. Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs).
Stepanova D; Beran RG
Seizure; 2014 May; 23(5):371-6. PubMed ID: 24630809
[TBL] [Abstract][Full Text] [Related]
40. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy.
Glien M; Brandt C; Potschka H; Löscher W
Epilepsia; 2002 Apr; 43(4):350-7. PubMed ID: 11952764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
